
    
      By enrolling patients with unresectable Head and Hilus Pulmonis adapted to enrolled criteria,
      this study will document for the first time the safety and the short and long term efficacy
      of percutaneous IRE for unresectable Hilus Pulmonis Neoplasms.
    
  